Skip to content

pain relief following Caesarean section with peripheral nerve block

â??Comparison of efficacy of Bupivacaine with Dexmedetomidine versus Bupivacaine alone for Transversus Abdominis Plane block for Post â??operative Analgesia in patients undergoing elective Caesarean section.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/12/010778
Enrollment
70
Registered
2017-12-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- healthy parturients admitted for caesarean section

Interventions

Intervention1: Dexmedetomidine with bupivacaine in Transversus abdominis plane block: Use of 0.5mcg/kg of dexmedetomidine with 0.25% bupivacaine in Transversus abdominis plane block for post operative

Sponsors

sri ramakrishna hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Parturients of American society of Anaesthesiologists class I and Ii

Exclusion criteria

Exclusion criteria: 1.Patient refusal, 2.drug allergy to study medications, 3.localised infection over site of injection, 4.significant coagulopathies and 5.contraindications to regional anaesthesia, 6.patients with heart disease, 7.altered renal or liver functions, 8.psychological disorders, 9.patients with pregnancy induced hypertension and diabetes mellitus, 10.chronic use of pain medicines, and 11.BMI >35 or weight <50kg.

Design outcomes

Primary

MeasureTime frame
time at which first rescue analgesia was sought after the TAP blockTimepoint: VAS score for assessing pain

Secondary

MeasureTime frame
total dose of opioids used in the first 24 hoursTimepoint: pain monitored on VAS scsle

Countries

India

Contacts

Public Contactramya parameswari arjunan

Sri Ramakrishna Hospital

arjunanramya@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026